LUCILENO RODRIGUES DA TRINDADE

Mr. LUCILENO RODRIGUES DA TRINDADE

Universidade Federal do Rio de Janeiro – UFRJ

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2021 in Molecules
Verified
Journal Article
Open access
PDF file
LUCILENO RODRIGUES DA TRINDADELUCILENO RODRIGUES DA TRINDADE
LUCILENO RODRIGUES DA TRINDADE
DSDavi Vieira Teixeira da Silva
Davi Vieira Teixeira da Silva
DBDiego dos Santos Baião
Diego dos Santos Baião
Vania Margaret Flosi PaschoalinVania Margaret Flosi Paschoalin
Vania Margaret Flosi Paschoalin
Polyphenols play a therapeutic role in vascular diseases, acting in inherent illness-associate conditions such as inflammation, diabetes, dyslipidemia, hypertension, and oxidative stress, as demonstrated by clinical trials and epidemiological surveys. The main polyphenol cardioprotective mechanisms rely on increased nitric oxide, decreased asymmetric dimethylarginine levels, upregulation of genes encoding antioxidant enzymes via the Nrf2-ARE pathway and anti-inflammatory action through the redox-sensitive transcription factor NF-κB and PPAR-γ receptor. However, poor polyphenol bioavailability and extensive metabolization restrict their applicability. Polyphenols carried by nanoparticles circumvent these limitations providing controlled release and better solubility, chemical protection, and target achievement. Nano-encapsulate polyphenols loaded in food grade polymers and lipids appear to be safe, gaining resistance in the enteric route for intestinal absorption, in which the mucoadhesiveness ensures their increased uptake, achieving high systemic levels in non-metabolized forms. Nano-capsules confer a gradual release to these compounds, as well as longer half-lives and cell and whole organism permanence, reinforcing their effectiveness, as demonstrated in pre-clinical trials, enabling their application as an adjuvant therapy against cardiovascular diseases. Polyphenol entrapment in nanoparticles should be encouraged in nutraceutical manufacturing for the fortification of foods and beverages. This study discusses pre-clinical trials evaluating how nano-encapsulate polyphenols following oral administration can aid in cardiovascular performance.

2 April 2023 in Foods
Verified
Journal Article
Open access
PDF file
LUCILENO RODRIGUES DA TRINDADELUCILENO RODRIGUES DA TRINDADE
LUCILENO RODRIGUES DA TRINDADE
DBDiego dos Santos Baião
Diego dos Santos Baião
DSDavi Vieira Teixeira da Silva
Davi Vieira Teixeira da Silva
CACristine Almeida
Cristine Almeida
FPFernanda Petzold Pauli
Fernanda Petzold Pauli
Vania Margaret Flosi PaschoalinVania Margaret Flosi Paschoalin
Vania Margaret Flosi Paschoalin
Beetroot is a tuber rich in antioxidant compounds, i.e., betanin and saponins, and is one of the main sources of dietary nitrate. The aim of the present study was to microencapsulate a ready-to-eat beetroot soup by lyophilization using different encapsulating agents, which supply the required amount of bioactive nutrients. Particle size distributions ranged from 7.94 ± 1.74 to 245.66 ± 2.31 µm for beetroot soup in starch and from 30.56 ± 1.66 to 636.34 ± 2.04 µm in maltodextrin. Microparticle yields of powdered beetroot soup in starch varied from 77.68% to 88.91%, and in maltodextrin from 75.01% to 80.25%. The NO3− and total betalain contents at a 1:2 ratio were 10.46 ± 0.22 mmol·100 g−1 fresh weight basis and 219.7 ± 4.92 mg·g−1 in starch powdered beetroot soup and 8.43 ± 0.09 mmol·100 g−1 fresh weight basis and 223.9 ± 4.21 mg·g−1 in maltodextrin powdered beetroot soup. Six distinct minerals were identified and quantified in beetroot soups, namely Na, K, Mg, Mn, Zn and P. Beetroot soup microencapsulated in starch or maltodextrin complied with microbiological quality guidelines for consumption, with good acceptance and purchase intention throughout 90 days of storage. Microencapsulated beetroot soup may, thus, comprise a novel attractive strategy to offer high contents of bioaccessible dietary nitrate and antioxidant compounds that may aid in the improvement of vascular-protective effects.

27 April 2026 in Polysaccharides
Verified
Journal Article
Open access
PDF file
LOLiliane Siqueira de Oliveira
Liliane Siqueira de Oliveira
DSDavi Vieira Teixeira da Silva
Davi Vieira Teixeira da Silva
LUCILENO RODRIGUES DA TRINDADELUCILENO RODRIGUES DA TRINDADE
LUCILENO RODRIGUES DA TRINDADE
DBDiego dos Santos Baião
Diego dos Santos Baião
CACristine Almeida
Cristine Almeida
Vania Margaret Flosi PaschoalinVania Margaret Flosi Paschoalin
Vania Margaret Flosi Paschoalin
Polysaccharide-based microparticles have emerged as suitable carriers and stabilizers of active substances, showing potential to stabilize bioactive compounds during storage and gastrointestinal digestion, thereby improving their bioaccessibility and bioavailability. This narrative review provides a comprehensive overview of the main polysaccharides employed as wall materials, including starch, maltodextrin, alginate, pectin, inulin, chitosan, and gum Arabic, and discusses how structural interactions and physicochemical properties can positively influence the microencapsulation of polyphenols and pigments. The principles and main findings of the main microencapsulation techniques, including spray-drying, freeze-drying, extrusion, emulsification, and coacervation, are briefly described. Polysaccharides can entrap both hydrophilic and hydrophobic compounds through physical interactions, forming a barrier around the nucleus or binding to the bioactive compound. Intermolecular binding between polysaccharides in the wall matrix, polyphenols, and pigments in the nucleus can confer up to 90% encapsulation efficiency, primarily governed by hydrogen bonds and electrostatic interactions. The mixture of wall polysaccharides in the microparticles synthesis favors the encapsulation solubility, storage stability, bioaccessibility, and bioactivity of the microencapsulate compounds. Clinical trials regarding the bioefficacy of polyphenols and pigments loaded in polysaccharide microparticles are scarce and require further evidence to reinforce the use of this technology.

10 November 2025 in arXiv
Verified
Preprint
Open access
PDF file
LOLiliane Siqueira de Oliveira
Liliane Siqueira de Oliveira
DSDavi Vieira Teixeira da Silva
Davi Vieira Teixeira da Silva
LUCILENO RODRIGUES DA TRINDADELUCILENO RODRIGUES DA TRINDADE
LUCILENO RODRIGUES DA TRINDADE
DBDiego dos Santos Baião
Diego dos Santos Baião
CACristine Almeida
Cristine Almeida
Vania Margaret Flosi PaschoalinVania Margaret Flosi Paschoalin
Vania Margaret Flosi Paschoalin
Food polysaccharides have emerged as suitable carriers of active substances and as additives to food and nutraceutical formulations, showing potential to stabilize bioactive compounds during the storage of microencapsulate preparations, even in the gastrointestinal tract following the intake of bioactive compounds, thereby improving their bioaccessibility and bioavailability. This review provides a comprehensive overview of the main polysaccharides employed as wall materials, including starch, maltodextrin, alginate, pectin, inulin, chitosan, and gum arabic, and discusses how structural interactions and physicochemical properties can benefit the microencapsulation of polyphenols and pigments. The main findings and principles of the major encapsulation techniques, including spray drying, freeze drying, extrusion, emulsification, and coacervation, related to the production of microparticles, were briefly described. Polysaccharides can entrap hydrophilic and hydrophobic compounds by physical interactions, forming a barrier around the nucleus or binding to the bioactive compound. Intermolecular binding between polysaccharides in the wall matrix, polyphenols, and pigments in the nucleus can confer up to 90% of encapsulation efficiency, governed mainly by hydrogen bonds and electrostatic interactions. The mixture of wall polysaccharides in the microparticles synthesis favors the encapsulation solubility, storage stability, bioaccessibility, and bioactivity of the microencapsulate compounds. Clinical trials on the bioefficacy of polyphenols and pigments loaded in polysaccharide microparticles are scarce and require further evidence to reinforce the use of this technology.

13 April 2026 in Foods
Verified
Journal Article
Open access
PDF file
LUCILENO RODRIGUES DA TRINDADELUCILENO RODRIGUES DA TRINDADE
LUCILENO RODRIGUES DA TRINDADE
DBDiego dos Santos Baião
Diego dos Santos Baião
DSDavi Vieira Teixeira da Silva
Davi Vieira Teixeira da Silva
FPFernanda Petzold Pauli
Fernanda Petzold Pauli
Vania Margaret Flosi PaschoalinVania Margaret Flosi Paschoalin
Vania Margaret Flosi Paschoalin
Background: Beets are enriched in bioactive compounds with beneficial effects on cardiovascular function. Nitrate is a precursor for nitric oxide synthesis, exhibiting an effect on cardiomyocytes and myocardial ischemia/reperfusion, improving endothelial function and reducing arterial stiffness. Betanin, saponins and phenolic compounds, other beet compounds, can limit the generation of reactive oxygen species and modulate gene expression. However, it has been a challenge to develop beetroot formulations for the oral administration of these compounds while preserving pleasant sensory characteristics. Objective: The objective of this study was to develop an innovative dairy–beetroot powder drink, microencapsulated in polysaccharides, i.e., maltodextrin, cassava starch or a combination of both, that could be easily reconstituted. Key Results: The microencapsulated formulation following freeze-drying displayed low water activity (90%), with rapid dispersion in aqueous medium. Fourier transform infrared spectroscopy confirmed the preservation of functional groups from the dairy base and sugar beetroots. Thermogravimetry analyses pointed out a slight increase in thermal stability for the powder formulation. The microencapsulation efficiency of betalains reached 81% in the powder formulation that combined cassava starch and maltodextrin as encapsulation agents. The novel dairy–beetroot powder drink can be stored at room temperature, ensuring microbiological safety and preserving good sensory acceptance. Conclusions: Dairy–beetroot powder microcapsules emerge as an efficient food strategy to provide bioaccessible dietary nitrate and antioxidant compounds, overcoming flavor and stability limitations but still aiding in terms of its vascular and hemodynamic-protective effects.